{"id":259403,"date":"2018-06-14T22:13:03","date_gmt":"2018-06-14T22:13:03","guid":{"rendered":"http:\/\/www.hier-luebeck.de\/politik-wirtschaft\/haematologen-aus-ganz-europa-treffen-sich-vom-14-17-juni-2018-in-stockholm-schweden-um-durchbrueche-bei-blutkrankheiten-zu-diskutieren\/"},"modified":"2018-06-14T22:13:03","modified_gmt":"2018-06-14T22:13:03","slug":"haematologen-aus-ganz-europa-treffen-sich-vom-14-17-juni-2018-in-stockholm-schweden-um-durchbrueche-bei-blutkrankheiten-zu-diskutieren","status":"publish","type":"post","link":"https:\/\/hier-luebeck.de\/index.php\/haematologen-aus-ganz-europa-treffen-sich-vom-14-17-juni-2018-in-stockholm-schweden-um-durchbrueche-bei-blutkrankheiten-zu-diskutieren\/","title":{"rendered":"H\u00e4matologen aus ganz Europa treffen sich vom 14.-17. Juni 2018 in Stockholm (Schweden), um Durchbr\u00fcche bei Blutkrankheiten zu diskutieren"},"content":{"rendered":"

Stockholm (ots\/PRNewswire) – Zum bevorstehenden 23. Kongress der European Hematology Association (EHA) im Stockholmsm\u00e4ssan (Stockholm, Schweden) vom 14.-17. Juni 2018 werden mehr als 11.000 Teilnehmer erwartet. Pr\u00e4sentiert werden die neuesten Entwicklungen und Forschungsdaten zu Blutkrankheiten; zudem lanciert die EHA zwei neue Programme zu Immuntherapie und H\u00e4moglobinopathien (Logo: http:\/\/mma.prnewswire.com\/media\/622259\/EHA_Logo.jpg ) Ausz\u00fcge werden im Rahmen zweiter Presseveranstaltungen vor Medienvertretern pr\u00e4sentiert. Freitag, 15. Juni 2018 von 8.30-10.00 Uhr MESZ, Raum K11 Moderator: Elizabeth Macintyre Abstract Referent Titel S138 Jesus G. Berdeja Update on bb2121, a promising therapy for patients with heavily pre-treated relapsed\/refractory multiple myeloma S110 Olivier Casasnovas AHL2011: Outstanding disease control with a minimized BEACOPP exposure and toxicity in patients with advanced Hodgkin lymphoma S149 Fang Liu First-in-Human CLL1-CD33 Compound CAR T Cells as a Two-pronged Approach for the treatment of refractory acute myeloid leukemia S151 Valentin Goede Overall survival benefit of obinutuzumab over rituximab when combined with chlorambucil in patients with chronic lymphocytic leukemia and comorbidities S154 Frank Morschhauser Is RELEVANCE Relevant? Results of the phase III study of R2 vs R-chemo in first-line follicular lymphoma S152 Francesca Vinchi Iron: a double-edged sword in inflammation Samstag, 16. Juni 2018 von 8.30-09.30 Uhr MESZ, Raum K11 Moderator: Ton Hagenbeek Abstract Referent Title S832 Jing Pan New anti-CD22 CAR-T immunotherapy saved life of children with leukemia S852 Meletios iNNOVATE Study: Ibrutinib plus Rituximab for Dimopoulos Patients with Waldenstr\u00f6m’s Macroglobulinemia S802 Laurie H. Sehn Answering the unmet need in one of the most common types of lymphoma: It’s as simple as A-D-C Neben diesen Abstracts wird am Samstag, den 16. Juni ein neues EHA-Programm mit dem Titel „Topics-in-Focus“ vorgestellt: – 09.05-09.10 Uhr: Immunotherapy -> Making CAR-T cells happen in Europe, John Gribben, Barts Cancer Institute, London, Vereinigtes K\u00f6nigreich – 09.15-09.20 Uhr: Hemoglobinopathies -> From the basics of sickle cell disease to where we are now, Maria Cappellini, Universit\u00e4t Mailand-Stiftung IRCCS Policlinico (Poliklinikum), Italien. Embargo Bitte beachten Sie, dass alle ausgew\u00e4hlten Abstracts in diesen Presseveranstaltungen unseren Embargorichtlinien unterliegen. Weitere Informationen finden Sie in unseren Medienrichtlinien zum Kongress (https:\/\/ehaweb.org\/congress\/23rd-c\/media\/). Das Programm f\u00fcr den 23. Kongress finden Sie hier. Website: http:\/\/www.ehaweb.org Original-Content von: European Hematology Association (EHA), \u00fcbermittelt durch news aktuell<\/p>\n

Quelle: presseportal.de<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Stockholm (ots\/PRNewswire) – Zum bevorstehenden 23. Kongress der European Hematology Association (EHA) im Stockholmsm\u00e4ssan (Stockholm, Schweden) vom 14.-17. Juni 2018<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"colormag_page_container_layout":"default_layout","colormag_page_sidebar_layout":"default_layout","footnotes":""},"categories":[5],"tags":[],"class_list":["post-259403","post","type-post","status-publish","format-standard","hentry","category-politik-wirtschaft"],"_links":{"self":[{"href":"https:\/\/hier-luebeck.de\/index.php\/wp-json\/wp\/v2\/posts\/259403","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hier-luebeck.de\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hier-luebeck.de\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hier-luebeck.de\/index.php\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/hier-luebeck.de\/index.php\/wp-json\/wp\/v2\/comments?post=259403"}],"version-history":[{"count":0,"href":"https:\/\/hier-luebeck.de\/index.php\/wp-json\/wp\/v2\/posts\/259403\/revisions"}],"wp:attachment":[{"href":"https:\/\/hier-luebeck.de\/index.php\/wp-json\/wp\/v2\/media?parent=259403"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hier-luebeck.de\/index.php\/wp-json\/wp\/v2\/categories?post=259403"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hier-luebeck.de\/index.php\/wp-json\/wp\/v2\/tags?post=259403"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}